Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients
Clinical trial NCT02921789 · COMPLETED
Trial details
- NCT number
- NCT02921789
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-22
- Primary completion
- 2020-12-11
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.